Specific considerations in female patients with patellar instability: current concepts
Francisco Figueroa1, Rodrigo Guiloff1, Sarah Bolton2
1Clinica Alemana-Universidad del Desarrollo, 7650568, Chile; Hospital Sotero del Rio, 8207257, Chile.
Summary
Patellofemoral instability (PFI) is more common in women due to anatomical differences. Personalized treatment plans addressing individual risk factors may improve surgical outcomes for female patients.
Area of Science:
- Orthopedic Surgery
- Biomedical Engineering
- Sports Medicine
Background:
- Patellofemoral instability (PFI) demonstrates higher prevalence in female populations.
- Anatomical sex differences, including trochlear dysplasia, patella alta, increased Q angle, and soft tissue imbalances, contribute to PFI in women.
- Worse outcomes are reported in female patients post-patellofemoral stabilization surgery.
Purpose of the Study:
- To investigate the anatomical factors contributing to patellofemoral instability (PFI) in female patients.
- To evaluate the efficacy of current surgical interventions for PFI in women.
- To propose an individualized treatment approach for female patients with PFI.
Main Methods:
- Review of existing literature on patellofemoral instability prevalence and contributing factors in males versus females.
- Analysis of surgical outcomes for patellofemoral stabilization procedures (MPFLr, TTO) in female patients.
- Exploration of anatomical risk factors and their correlation with surgical success.
Main Results:
- Significant anatomical differences exist between sexes, predisposing women to PFI.
- Current surgical strategies, including MPFLr and TTO, show suboptimal outcomes in female patients.
- Anatomical variations necessitate tailored surgical planning.
Conclusions:
- Female patients exhibit unique anatomical predispositions to patellofemoral instability.
- A standardized surgical approach may not be optimal for all female patients.
- An individualized, "à la carte" treatment strategy addressing specific anatomical risk factors is recommended for improved outcomes in female PFI patients.


